Otros idiomas PharmaCielo Ltd.

Acciones

PCLO

CA71716K1012

Diferido Toronto S.E. Otros sitios de cotización 16:29:07 07/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,155 ^CAD	-3,13 %		-.--%	-13,89 %

04/01	Benuvia y PharmaCielo anuncian una asociación estratégica para fabricar aislado de CBD de grado farmacéutico cGMP y productos relacionados	CI
2023	PharmaCielo Ltd. Resultados del tercer trimestre y nueve meses finalizados el 30 de septiembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Canadian Investment Regulatory Organization Trading Halt - PCLO	08/05
PharmaCielo Announces Issuance of Failure to File Cease Trade Order	08/05
PharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors	10/04
PharmaCielo Ltd. announced that it expects to receive CAD 2 million in funding	10/04
PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil	26/03
Colombian Government Continues its Support of Domestic Cannabis Industry - Resolution Extending THC Inventory Allowance Provides Immediate Benefit to PharmaCielo	01/03
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products	04/01
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products	04/01
PharmaCielo Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11
PharmaCielo Announces Q3 2023 Financial Results	29/11
PharmaCielo Raises $3.3 Million Under Non-Brokered Private Placement	06/10/23
PharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private Placement	06/10/23
PharmaCielo Ltd. announced that it has received CAD 4.78 million in funding	06/10/23
PharmaCielo Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/08/23
Pharmacielo Ltd. Appoints Marc Lustig as CEO	11/07/23
Pharmacielo Ltd. Announces Board Changes	11/07/23
PharmaCielo Ltd. announced that it expects to receive CAD 5 million in funding	29/06/23
PharmaCielo Ltd. announced that it has received CAD 12.825 million in funding	29/06/23
PharmaCielo Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	29/05/23
PharmaCielo Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	01/05/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas PharmaCielo Ltd.

Acciones

PCLO

CA71716K1012

Otros idiomas

Filtros